Immunogen (IMGN) Misses Q1 on Top and Bottom
Tweet
Share
E-mailGet Alerts IMGN Hot Sheet
Price: $31.25 --0%
Revenue Growth %: -100.0%
Financial Fact:
General and administrative: 9.46M
Today's EPS Names:
UXIN, TOWN, NRIM, More
Revenue Growth %: -100.0%
Financial Fact:
General and administrative: 9.46M
Today's EPS Names:
UXIN, TOWN, NRIM, More
Join SI Premium – FREE
Immunogen (NASDAQ: IMGN) reported Q1 EPS of ($0.26), $0.11 worse than the analyst estimate of ($0.15). Revenue for the quarter came in at $13.2 million versus the consensus estimate of $21.8 million.
For earnings history and earnings-related data on Immunogen (IMGN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Berenberg Starts Lloyds TSB Group (LYG) at Hold, 'shares are fairly valued'
- Ford (F) earnings top estimates in Q1 amid strength in Pro unit; stock up
- Meta Platforms Inc. (META) PT Lowered to $480 at JPMorgan, 'Bigger AI Ambitions Drive Increasing Infrastructure Investments'
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
